| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |